Regina HoditsManaging Partner at Wellington PartnersSpeaker
Profile
Regina is a Managing Partner at Wellington Partners Life Sciences WPLS and represents the WPLS funds on the Boards of Ayoxxa, Endostim, GTX Medical, Polares Medical, Themis and TRiCares. She was a founding investor in Rigontec (acquired by MSD), Sapiens (acquired by Medtronic), Middle Peak Medical (acquired by Symetis / Boston Scientific), and an external director at GlaxoSmithKline's Respiratory TA Board. Since joining the industry in 2000, she has become an influential investor in the European venture capital industry, focusing on early-stage and growth deals in Life Sciences. She currently serves as the Spokesperson for the Board of the German PE and Venture Capital Association (BVK).
Agenda Sessions
Life Science Executives in 2024: Evaluating a Critical Year of Shifting Approvals, Rejuvenated Funding, and Strategic Deals for Future Success
09:35View SessionLife Science Executives in 2024: Evaluating a Critical Year of Shifting Approvals, Rejuvenated Funding, and Strategic Deals for Future Success
, 09:35View Session